Spruce Biosciences Inc (SPRB)
0.7728
-0.03
(-3.40%)
USD |
NASDAQ |
May 16, 12:51
Spruce Biosciences Profit Margin (Quarterly): -580.7% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -580.7% |
December 31, 2023 | -344.6% |
September 30, 2023 | -402.0% |
Date | Value |
---|---|
June 30, 2023 | -592.3% |
March 31, 2023 | -651.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-651.3%
Minimum
Mar 2023
-344.6%
Maximum
Dec 2023
-514.2%
Average
-580.7%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | -8.74% |
ADMA Biologics Inc | 21.75% |
Coherus BioSciences Inc | -- |
TRACON Pharmaceuticals Inc | 14.42% |
First Wave BioPharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -53.98% |
Return on Assets | -41.04% |
Return on Invested Capital | -51.75% |
Operating Margin (Quarterly) | -631.0% |
Return on Net Operating Assets | -620.8% |